Cite

HARVARD Citation

    Plassmeyer, M. et al. (2022). Caspases and therapeutic potential of caspase inhibitors in moderate–severe SARS‐CoV‐2 infection and long COVID. Allergy. 77 (1), pp. 118-129. [Online]. 
  
Back to record